BriaCell Therapeutics Corp. (BCTX)
3.435
+0.02
(+0.73%)
USD |
NASDAQ |
Oct 23, 16:00
3.42
-0.02
(-0.44%)
After-Hours: 20:00
BriaCell Therapeutics Net Income (Quarterly) : -7.237M for April 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | -7.237M |
| January 31, 2026 | -7.297M |
| October 31, 2025 | -8.278M |
| July 31, 2025 | -8.164M |
| April 30, 2025 | -6.225M |
| January 31, 2025 | -6.338M |
| October 31, 2024 | -5.829M |
| July 31, 2024 | -1.249M |
| April 30, 2024 | 1.692M |
| January 31, 2024 | -11.33M |
| October 31, 2023 | 5.959M |
| July 31, 2023 | -2.419M |
| April 30, 2023 | -4.895M |
| January 31, 2023 | -11.88M |
| October 31, 2022 | -1.106M |
| April 30, 2022 | -10.02M |
| January 31, 2022 | 11.16M |
| October 31, 2021 | -27.53M |
| April 30, 2021 | 2.950M |
| January 31, 2021 | -0.2252M |
| October 31, 2020 | -0.368M |
| July 31, 2020 | -0.5089M |
| April 30, 2020 | -0.5086M |
| January 31, 2020 | -1.430M |
| October 31, 2019 | -1.244M |
| Date | Value |
|---|---|
| July 31, 2019 | -1.276M |
| April 30, 2019 | -1.144M |
| January 31, 2019 | -1.190M |
| October 31, 2018 | -0.8041M |
| July 31, 2018 | -1.644M |
| April 30, 2018 | -1.298M |
| January 31, 2018 | -0.7719M |
| October 31, 2017 | -0.5127M |
| July 31, 2017 | -0.8996M |
| April 30, 2017 | -0.883M |
| January 31, 2017 | -0.3111M |
| October 31, 2016 | -0.3351M |
| July 31, 2016 | -0.2984M |
| April 30, 2016 | -0.3219M |
| January 31, 2016 | -0.7264M |
| October 31, 2015 | -0.3062M |
| July 31, 2015 | -0.298M |
| April 30, 2015 | -0.3715M |
| January 31, 2015 | -2.224M |
| October 31, 2014 | -0.1188M |
| July 31, 2014 | -7.440M |
| April 30, 2014 | -0.5337M |
| January 31, 2014 | -0.083M |
| October 31, 2013 | -0.1534M |
| July 31, 2013 | -0.1011M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Edesa Biotech, Inc. | -5.408M |
| ProMIS Neurosciences, Inc. | -11.73M |
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 7.164M |
| EPS Diluted (Quarterly) | -0.9881 |
| Enterprise Value | 1.452M |
| Earnings Yield | -355.5% |
| Normalized Earnings Yield | -362.85 |